LLNI Funded Publications
Synergistic effects of proteasome inhibitor carfilzomib in combination with tyrosine kinase inhibitors in imatinib-sensitive and -resistant chronic myeloid leukemia models.
Author:Crawford LJ
Other Authors: Chan ET, Aujay M, Holyoake TL, Melo JV, Jorgensen HG, Suresh S, Walker B, Irvine AE,
Last Updated:04/11/2019
Source:PubMed
Original Source:PubMed
Type:Journal Article
DOI:10.1038/oncsis.2014.3
Journal:Oncogenesis
Volume:3
Pages:e90
Date: March 2014
